Abstract | OBJECTIVE: DESIGN: An open, comparative, randomised, monocentric study. SUBJECTS: A hundred and eighteen patients (85 endometritis and 33 salpingitis) were included. Clinical, laparoscopic and bacteriological assessments were performed before treatment. 30.4% of salpingitis were considered as severe (COGIT score > 6). 25.4% of acute pelvic infections were only caused by Chlamydia trachomatis. TREATMENT: A hundred and eighteen patients were treated orally with 3 week combination ofloxacin (200 mg b.i.d.) + coamoxiclav (1 g b.i.d.) (n = 60) or with a 6 week coamoxiclav (1 g b.i.d.) + doxycycline (100 mg b.i.d.) (n = 58). RESULTS: Oral combination ofloxacin- coamoxiclav is as effective as oral combination doxycycline+coamoxyclav with respectively 96.7% versus 96.6% and 100% versus 98.4% satisfactory clinical et bacteriological results.
|
Authors | P Judlin, A Koebele, A Zaccabri, E van Walleghen, A Pavis, Y Badonnel, M Dailloux, P Landes |
Journal | Journal de gynecologie, obstetrique et biologie de la reproduction
(J Gynecol Obstet Biol Reprod (Paris))
Vol. 24
Issue 3
Pg. 253-9
( 1995)
ISSN: 0368-2315 [Print] France |
Vernacular Title | Etude comparative des associations ofloxacine+amoxicilline-acide clavulanique versus doxycycline+amoxicilline-acide clavulanique dans le traitement des infections génitales hautes à Chlamydia trachomatis. |
PMID | 7622771
(Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Clavulanic Acids
- Amoxicillin-Potassium Clavulanate Combination
- Amoxicillin
- Ofloxacin
- Doxycycline
|
Topics |
- Adolescent
- Adult
- Amoxicillin
(therapeutic use)
- Amoxicillin-Potassium Clavulanate Combination
- Chlamydia Infections
(drug therapy, microbiology)
- Chlamydia trachomatis
- Clavulanic Acids
(therapeutic use)
- Doxycycline
(therapeutic use)
- Drug Therapy, Combination
(therapeutic use)
- Endometritis
(drug therapy, microbiology)
- Female
- Humans
- Ofloxacin
(therapeutic use)
- Salpingitis
(drug therapy, microbiology)
- Severity of Illness Index
- Treatment Outcome
|